Liquidia (LQDA) Total Liabilities (2019 - 2026)
Liquidia (LQDA) posted quarterly Total Liabilities of $293.0 million for Q1 2026, up 64.84% year-over-year from $177.7 million in Q1 2025, and up 3.45% quarter-over-quarter from $283.2 million in Q4 2025.
Liquidia (LQDA) Total Liabilities (2019 - 2026) Analysis & Trends
Liquidia's Total Liabilities history runs 8 years deep, the most recent figure standing at $293.0 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 64.84% year-over-year to $293.0 million; the TTM figure through Mar 2026 stood at $293.0 million (up 64.84% YoY), while the FY2025 annual figure was $283.2 million, up 87.62% from the prior year.
- Total Liabilities for Q1 2026 stood at $293.0 million, up from $283.2 million in the prior quarter.
- The five-year high for Total Liabilities was $293.0 million in Q1 2026, with the low at $37.0 million in Q2 2022.
- The 5-year median for Total Liabilities is $100.0 million (2024), against an average of $126.6 million.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities climbed 23.97% in 2023, then surged 123.73% in 2024.
- Liquidia's Total Liabilities stood at $38.8 million in 2022, then jumped by 83.2% to $71.0 million in 2023, then jumped by 112.47% to $150.9 million in 2024, then jumped by 87.62% to $283.2 million in 2025, then gained by 3.45% to $293.0 million in 2026.
- Business Quant data shows LQDA's Total Liabilities at $293.0 million in Q1 2026, $283.2 million in Q4 2025, and $253.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Liquidia | 6.39 Bn | 6.11 Bn | 160.92 Mn | 326.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 326.80 Mn |
| Mar 31, 2026 | 292.95 Mn |
| Dec 31, 2025 | 283.19 Mn |
| Sep 30, 2025 | 253.93 Mn |
| Jun 30, 2025 | 242.22 Mn |
| Mar 31, 2025 | 177.72 Mn |
| Dec 31, 2024 | 150.94 Mn |
| Sep 30, 2024 | 142.37 Mn |
| Jun 30, 2024 | 114.64 Mn |
| Mar 31, 2024 | 100.01 Mn |
| Dec 31, 2023 | 71.04 Mn |
| Sep 30, 2023 | 63.64 Mn |
| Jun 30, 2023 | 60.94 Mn |
| Mar 31, 2023 | 47.28 Mn |
| Dec 31, 2022 | 38.78 Mn |
| Sep 30, 2022 | 37.53 Mn |
| Jun 30, 2022 | 36.98 Mn |
| Mar 31, 2022 | 38.14 Mn |
| Dec 31, 2021 | 28.46 Mn |
| Sep 30, 2021 | 27.34 Mn |